OmniAb Inc Sustainability Reports
OmniAb, Inc. provides therapeutic antibody discovery technologies and platforms to pharmaceutical and biotechnology companies. The company's technology generates diverse repertoires of high-quality antibodies for the development of therapeutics.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG011J3QM48
4 reports from 2022 to 2025
